Partner Nate Lacktman was quoted in a Bloomberg BNA article, “New State Telemedicine Laws Show Provider Hurdles Remain,” covering the pros and cons of the new telemedicine laws in Oklahoma and Texas, and the evolution of telemedicine as a whole.
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”